[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Clinuvel Pharmaceuticals Ltd (CLVLY)

Clinuvel Pharmaceuticals Ltd (CLVLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.6500 +10.53%
on 06/25/26
7.6700 -4.17%
on 07/02/26
-0.0100 (-0.14%)
since 06/17/26
3-Month
5.9800 +22.91%
on 05/19/26
7.6700 -4.17%
on 07/02/26
+0.6100 (+9.05%)
since 04/17/26
52-Week
5.9800 +22.91%
on 05/19/26
9.0000 -18.33%
on 08/27/25
+0.2500 (+3.52%)
since 07/17/25

Most Recent Stories

More News
A decade of profitability provides foundation for CLINUVEL’s U.S. expansion

CLINUVEL PHARMACEUTICALS LTD announced its tenth consecutive annual profit and further rise in free cash in the financial year ended 30 June 2026...

CUVL : 6.77 (-11.44%)
CLVLY : 7.3500 (+3.09%)
CUV.AX : 9.180 (-12.74%)
CLINUVEL implements strategic reorganisation to refocus on U.S. markets

MELBOURNE, Australia and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic...

CUVL : 6.77 (-11.44%)
CLVLY : 7.3500 (+3.09%)
CUV.AX : 9.180 (-12.74%)
CLINUVEL’s ADS to commence trading on Nasdaq

CUVL to trade on the highest tier – Global Select Market...

CLVLY : 7.3500 (+3.09%)
CUV.AX : 9.180 (-12.74%)
CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study

“Totality of evidence” approach to evaluate SCENESSE®...

CLVLY : 7.3500 (+3.09%)
CUV.AX : 9.180 (-12.74%)
CLINUVEL: advancing peptides for photomedicine and vitiligo care at AAD 2026

AAD 2026 reinforces CLINUVEL’s expertise in dermatology...

CLVLY : 7.3500 (+3.09%)
CUV.AX : 9.180 (-12.74%)
CLINUVEL expands Singapore RD&I Centre to pioneer next-generation peptide therapies

EXECUTIVE SUMMARY VALLAURIX Research, Development & Innovation Centre to expand its existing facilities and capabilities core focus on accelerating...

CLVLY : 7.3500 (+3.09%)
CUV.AX : 9.180 (-12.74%)
CLINUVEL to advance novel pharmaceutical formulations in preclinical program

Next generation sustained-release formulations for a variety of peptides...

CLVLY : 7.3500 (+3.09%)
CUV.AX : 9.180 (-12.74%)
CLINUVEL preparing upgrade of ADR program to Level II, Nasdaq uplist

Executive summary plan to upgrade American Depository Receipt (ADR) program (CLVLY) to a Level II ADR listed on Nasdaq, expected before the end of...

CLVLY : 7.3500 (+3.09%)
CUV.AX : 9.180 (-12.74%)

Key Turning Points

3rd Resistance Point 7.7267
2nd Resistance Point 7.6233
1st Resistance Point 7.4867
Last Price 7.3500
1st Support Level 7.2467
2nd Support Level 7.1433
3rd Support Level 7.0067

See More

52-Week High 9.0000
Fibonacci 61.8% 7.8464
Fibonacci 50% 7.4900
Last Price 7.3500
Fibonacci 38.2% 7.1336
52-Week Low 5.9800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.